OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9815	Companies
196906	Keywords
127965	Articles
104714	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 05/28/2025 at 18:00, 8 months 8 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelenbezit volgens Belgische wetgeving. Bedrijf combineert therapeutische innovatie met klinisch onderzoekstechnologieën

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Bedrijf Belgische Wetgeving Atlas Special Opportunities II LLC
BRIEF

published on 05/22/2025 at 18:05, 8 months 14 days ago

Résultats de l'Assemblée Générale d'Oxurion

Actionnaires Assemblée Générale Titres Déclarations Prospectives Oxurion
BRIEF

published on 05/22/2025 at 18:05, 8 months 14 days ago

Results of the Oxurion General Meeting

Securities Shareholders Forward-looking Statements General Assembly Oxurion
PRESS RELEASE

published on 05/22/2025 at 18:00, 8 months 14 days ago

Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 13 mei 2025
Oxurion NV hield succesvol zijn jaarlijkse aandeelhoudersvergadering op 13 mei 2025. Alle agenda-items werden goedgekeurd. Meer informatie beschikbaar op www.oxurion.com

Euronext Brussel Oxurion NV Aandeelhoudersvergadering Biofarmaceutisch België
PRESS RELEASE

published on 05/22/2025 at 18:00, 8 months 14 days ago

Oxurion Announces Results on the Annual Shareholders' Meeting of 13 May 2025
Oxurion NV held its annual shareholders' meeting on May 13, 2025, in Leuven, Belgium. Shareholders approved all agenda items. Find more on Oxurion's website

Biopharmaceutical Clinical Data Euronext Brussels Annual Shareholders' Meeting Oxurion NV
BRIEF

published on 05/20/2025 at 18:05, 8 months 16 days ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
BRIEF

published on 05/20/2025 at 18:05, 8 months 16 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 05/20/2025 at 18:00, 8 months 16 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding shareholding percentages falling below thresholds. Atlas Special Opportunities II LLC sold voting securities affecting percentages. Visit www.oxurion.com for more info

Belgium Oxurion NV Transparency Notifications Shareholding Percentages Biofarmaceutical Company
PRESS RELEASE

published on 05/20/2025 at 18:00, 8 months 16 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding changes in share ownership per Belgian Transparency legislation. Oxurion is a biopharmaceutical company developing ophthalmic therapies

Biopharmaceutical Share Ownership Ophthalmic Therapies Oxurion NV Transparency Notifications
BRIEF

published on 05/16/2025 at 08:35, 8 months 20 days ago

Oxurion to Acquire Majority Stake in Axiodis CRO

Acquisition Revenue Growth Oxurion Axiodis CRO Clinical Biometrics

Accesswire

Published on 02/06/2026 at 03:50, 1 hour 50 minutes ago

High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 2 hours 55 minutes ago

High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 4 hours 43 minutes ago

Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 5 hours 40 minutes ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 6 hours 25 minutes ago

Amarc Further Expands Its Toodoggone Technical Team

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 19:27, 10 hours 12 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 10 hours 53 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 11 hours 30 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 11 hours 44 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 11 hours 59 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.

Les Echos

Published on 02/05/2026 at 19:24, 10 hours 15 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 10 hours 15 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 10 hours 25 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 10 hours 25 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 10 hours 25 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE